(Q36918036)

17 August 2017

1 reference

title

Ocular drug delivery: nanomedicine applications (English)

1 reference

17 August 2017

1 reference

0 references

Jo Vandervoort

1

1 reference

17 August 2017

Annick Ludwig

series ordinal

2

1 reference

17 August 2017

publication date

1 February 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

2

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

11-21

1 reference

Review: systemic absorption of topically applied ocular drugs in humans

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Ophthalmic drug delivery systems--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Vesicular systems in ocular drug delivery: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

The use of mucoadhesive polymers in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

The potential of chitosan in ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Cationic vectors in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Improved ocular bioavailability of indomethacin by novel ocular drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Design of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Drug delivery systems for vitreoretinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

A New Class of Polymers: Starburst-Dendritic Macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Effect of subconjunctivally injected, liposome-bound, low-molecular-weight heparin on the absorption rate of subconjunctival hemorrhage in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Polycarboxylic acid nanoparticles for ophthalmic drug delivery: an ex vivo evaluation with human cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.1.11

21 January 2018

Identifiers

DOI

10.2217/17435889.2.1.11

1 reference

17 August 2017

1 reference